NAS:RYTM Key Ratios
| Market Cap $ M | 7,751.37 |
| Enterprise Value $ M | 7,535.02 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 75.02 |
| Price/Sales | 31.66 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 239.00 |
| EPS (TTM) $ | -3.11 |
| Beneish M-Score | -3.07 |
| 10-y EBITDA Growth Rate % | -10.50 |
| 5-y EBITDA Growth Rate % | -7.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -40.56 |
| EV-to-EBITDA | -40.79 |
| PEG | -- |
| Shares Outstanding M | 68.85 |
| Net Margin (%) | -85.59 |
| Operating Margin % | -83.62 |
| Pre-tax Margin (%) | -85.15 |
| Quick Ratio | 3.20 |
| Current Ratio | 3.45 |
| ROA % (ttm) | -45.85 |
| ROE % (ttm) | -88.96 |
| ROIC % (ttm) | -598.85 |
| Dividend Yield % | -- |
| Altman Z-Score | 16.32 |
RYTM Number of Guru Trades
RYTM Volume of Guru Trades
Gurus Latest Trades with NAS:RYTM
NAS:RYTM is held by these investors
Rhythm Pharmaceuticals Inc Insider Transactions
Guru Commentaries on NAS:RYTM
Rhythm Pharmaceuticals delivered on positive data and commercial catalysts, contributing to the overall strong performance in the biotech sector. The company is well-positioned to benefit from improving investor sentiment and positive trial results, which have been significant drivers in the recent gains within the industry. As the biotech index gained approximately 22%, Rhythm's performance reflects its potential for continued growth in a favorable market environment.
Rhythm Pharmaceuticals is a biopharmaceutical company focused on metabolic conditions related to genetic/injury-related obesity. The company has launched its main product in several rare indications, with likely approval for launching into a much larger indication in the near term. With a variety of pipeline candidates to enhance lifecycle management and address other related illnesses, we see robust growth potential ahead.
News about NAS:RYTM
Total 0- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
